Verve Therapeutics

United States
Panora, Iowa, United States, 02215

Company profile

Verve Therapeutics company profile

Verve Therapeutics develops genetic medicines that target cardiovascular diseases through innovative therapies. The company focuses on creating treatments that address the genetic causes of these conditions, aiming to transform how cardiovascular diseases are managed. As a clinical-stage organization, Verve is engaged in advancing its product candidates through rigorous research and development processes. The company emphasizes its commitment to improving patient outcomes by leveraging genetic insights to develop effective solutions. Verve Therapeutics continues to evolve in the field of genetic medicine, contributing to the future of cardiovascular health.

Business identity

Phone number
+1 617 603 0070
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
2018-01-01, Year

Headquarters

Postal code
02215
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
5
Total equity funding
$419.3M
Last funding
Post IPO Equity / $143.8M / 2023-11-28
Last equity funding
Post IPO Equity / $143.8M
Investors
17
Lead investors
4
Founders
7
Articles
369
Exited on
2021-06-16

Founders and investors

Founders

Anthony PhilippakisBarry TichoBurt AdelmanIssi RozenJ. Keith JoungKiran MusunuruSekar Kathiresan

Lead investors

Casdin CapitalEli LillyGoogle VenturesWellington Management

Investors

ARCH Venture PartnersCormorant Asset ManagementEli LillyRA Capital ManagementWellington Management